10x Genomics (TXG) Shares Outstanding (2018 - 2026)

10x Genomics has disclosed Shares Outstanding (Entity) across 9 years of filings, most recently posting $130.3 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 4.69% year-over-year to $130.3 million; the TTM figure through Jun 2026 stood at $130.3 million (up 4.69% YoY), while the FY2025 annual figure was $127.7 million, up 4.42% from the prior year.
• Shares Outstanding (Entity) came in at $130.3 million for Q2 2026 at 10x Genomics, up from $129.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $130.3 million in Q2 2026 to a low of $113.3 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $120.7 million, with a median of $120.1 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) grew 2.38% in 2022 and increased 4.75% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $115.2 million in 2022, then advanced by 3.39% to $119.1 million in 2023, then rose by 2.68% to $122.3 million in 2024, then gained by 4.42% to $127.7 million in 2025, then gained by 2.03% to $130.3 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $130.3 million in Q2 2026, $129.0 million in Q1 2026, and $127.7 million in Q4 2025.